Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002711022 | SCV003001185 | likely benign | Nemaline myopathy 2 | 2023-12-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004652027 | SCV005146327 | uncertain significance | Inborn genetic diseases | 2024-05-07 | criteria provided, single submitter | clinical testing | The c.17911G>A (p.E5971K) alteration is located in exon 131 (coding exon 129) of the NEB gene. This alteration results from a G to A substitution at nucleotide position 17911, causing the glutamic acid (E) at amino acid position 5971 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |